Article info
Original research
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers
- Correspondence to Dr Steven A Narod, Women's College Research Institute, Women's College Hospital, Toronto, ON M5S 1B2, Canada; steven.narod{at}wchospital.ca
Citation
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers
Publication history
- Received December 10, 2019
- Revision received January 24, 2020
- Accepted March 5, 2020
- First published April 30, 2020.
Online issue publication
February 08, 2021
Article Versions
- Previous version (1 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.